Respiratory virus surveillance and vaccination trends in New York and New Jersey

Public health data and commentary highlight the ongoing impact of seasonal respiratory viruses in the Northeastern United States. In New York, state health departments maintain a weekly dashboard tracking case and hospitalization data for influenza, COVID-19, and Respiratory Syncytial Virus (RSV) to inform public health responses.

In New Jersey, vaccination rates for influenza remain a concern, with approximately 60% of residents receiving the vaccine in 2024. Experts note that public hesitation is often driven by misconceptions regarding vaccine efficacy and the potential for temporary side effects, as well as an outdated manufacturing pipeline.